Pharmaceutical Executive July 15, 2024
The global president of endomechanical and energy for Johnson & Johnson MedTech discusses the need for multidisciplinary care when treating obesity.
The rise in popularity of GLP-1s has shined a spotlight on the need for obesity treatment. Sandeep Makkar, global president of endomechnical and energy for Johnson & Johnson MedTech spoke with Pharmaceutical Executive about how these medications should just be one method used by doctors and patients.
Pharmaceutical Executive: What are the most effective strategies for treating obesity on all fronts?
Sandeep Makkar: Obesity has emerged as one of the most pervasive and complex health challenges of the 21st century. Yet, there are still misconceptions around how it is diagnosed and treated.
Physicians, scientists, and major health organizations agree that...
Today's Sponsors
Today's Sponsor